- Home
- SPRY vs TFIN Comparison
SPRY vs TFIN Comparison
Compare SPRY & TFIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPRY
- TFIN
- Stock Information
- Founded
- SPRY 2015
- TFIN 1981
- Country
- SPRY United States
- TFIN United States
- Employees
- SPRY N/A
- TFIN N/A
- Industry
- SPRY Biotechnology: Pharmaceutical Preparations
- TFIN Major Banks
- Sector
- SPRY Health Care
- TFIN Finance
- Exchange
- SPRY Nasdaq
- TFIN Nasdaq
- Market Cap
- SPRY 1.1B
- TFIN 1.2B
- IPO Year
- SPRY N/A
- TFIN N/A
- Fundamental
- Price
- SPRY $8.79
- TFIN $53.58
- Analyst Decision
- SPRY Strong Buy
- TFIN Buy
- Analyst Count
- SPRY 4
- TFIN 4
- Target Price
- SPRY $31.25
- TFIN $62.00
- AVG Volume (30 Days)
- SPRY 1.7M
- TFIN 290.3K
- Earning Date
- SPRY 11-10-2025
- TFIN 10-15-2025
- Dividend Yield
- SPRY N/A
- TFIN N/A
- EPS Growth
- SPRY N/A
- TFIN N/A
- EPS
- SPRY N/A
- TFIN 0.28
- Revenue
- SPRY $112,339,000.00
- TFIN $412,291,000.00
- Revenue This Year
- SPRY N/A
- TFIN $10.55
- Revenue Next Year
- SPRY $193.13
- TFIN $10.89
- P/E Ratio
- SPRY N/A
- TFIN $191.64
- Revenue Growth
- SPRY 22367.80
- TFIN 3.78
- 52 Week Low
- SPRY $8.05
- TFIN $42.90
- 52 Week High
- SPRY $18.90
- TFIN $110.58
- Technical
- Relative Strength Index (RSI)
- SPRY 40.64
- TFIN 45.50
- Support Level
- SPRY $8.32
- TFIN $53.03
- Resistance Level
- SPRY $9.19
- TFIN $55.16
- Average True Range (ATR)
- SPRY 0.52
- TFIN 2.21
- MACD
- SPRY -0.04
- TFIN -0.33
- Stochastic Oscillator
- SPRY 36.10
- TFIN 9.38
About SPRY ARS Pharmaceuticals Inc.
ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the development of novel, potentially first-in-class product candidate, neffy for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows neffy to provide injection-like absorption of epinephrine at a low dose, in a small, easy-to-carry, easy-to-use, rapidly administered and reliable nasal spray.
About TFIN Triumph Financial Inc.
Triumph Financial Inc is a financial holding company. The company has four reportable segments namely Banking, Factoring, Payments, and Intelligence. The Banking segment includes the operations of TBK Bank. The Factoring segment includes the operations of Triumph Financial Services with revenue derived from factoring services, The Payments segment includes the operations of TBK Bank's TriumphPay division which provides a presentment, audit and payment solution to Shipper, Broker, and Factor clients in the trucking industry and The Intelligence segment includes to turn the over-the-road trucking data collected through the services into actionable insights for their customers.